Report Categories
View AllRecent Articles
View All
What Option OPCH is doing that separates it from the herd Slips 20260506
iShares MSCI Brazil ETF EWZ Rides Broad Emerging Market Rally Fueled by AI Boom and Energy Export Resilience
Why Voyager Therapeutics VYGR guidance matters more than actual results Q4 2025 EPS Beats Forecasts
What DHI Group DHX does that its rivals cannot On the Radar 20260505
Canadian Nat CNQ Q1 2026 Earnings Surprise EPS 117 Up Significant
Trumps Tariffs May Have Served Purposes Beyond Trade Policy Analysis Suggests
Beam Global BEEM Crushes Q4 2025 Estimates EPS 007 Tops Views
InflaRx NV IFRX Climbs 121 Resistance at 262 in Focus 20260518
Cheap AI Competition Could Complicate IPO Plans for OpenAI and Anthropic
Core Main CNM Q0 2026 Earnings Beat Revenue NA EPS 052
Marten Transport MRTN Stock Analysis 067 Loss Key Levels 20260521
Coupang CPNG Q1 2026 Results Miss Estimates EPS 015 vs 005
Tom Lees BitMine Executes Largest Ethereum Acquisition of 2026
GLP1 Weight Loss Drugs Driving Up Prescription Costs CoPays Expected to Rise
Cerus Corporation Receives Upgrade to Buy from BTIG Following First Quarter Results
SEC Advances TrumpBacked Proposal to Eliminate Mandatory Quarterly Earnings Reports
QatarEnergy and ExxonMobil Sign Deal to Export Cypriot Gas to Europe via Egypt
Kevin Warsh Set to Take Helm at Federal Reserve in White House Ceremony
Vishay Q1 2026 Earnings EPS Surges Past Estimates Shares Rally Over 12
SLSN Q1 2026 Earnings Slim Loss Provides Silver Lining Despite Opaque Revenue Picture
MGM Q1 2026 Earnings EPS Misses Estimates but Stock Gains Slightly
ERIE Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower
SOFI Q1 2026 Earnings EPS Just Below Consensus Shares Edge Lower
NTZ Q4 2011 Earnings EPS Misses Expectations Amid Challenging Environment
Intellia Therapeutics Slides Slightly Amid Cautious Trading in GeneEditing Sector
Yorkville Acquisition Corp Warrant MCGAW Rises 8 on Renewed Interest
Milestone Pharmaceuticals MIST Shows Modest Uptick Amid Consolidation Near Key Levels
BNY Mellon Strategic Municipal Bond Fund DSM holds steady near support with minor uptick
Gildan Activewear GIL Edges Higher Testing Resistance Zone Amid Modest Volume